This subproject is one of many research subprojects utilizing the resources provided by a Shared Instrumentation Grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the grant, which is not necessarily the institution for the investigator. DESCRIPTION (provided by applicant): An X-SPECT imaging system made by Gamma Medica, Inc. is requested in this Shared Instrument Grant application. X-SPECT(tm) is a dual-modality small animal imaging system that combines x-ray Computed Tomography (CT) and Single Photon Emission Computed Tomography (SPECT). Thus, X-SPECT(tm) is capable of generating co-registered anatomical (CT) and functional (SPECT) maps of intact animals under anesthesia. This instrument will allow 9 NIH- funded investigators to complete and significantly improve their studies on drug development, staging of tumor progression, and monitoring of gene delivery efficacy. Importantly, the instrument will enable the investigators to complete longitudinal studies in vivo without sacrifice of experimental animals. Consequently, investigators will study fewer animals but get much more data from each animal. The X-SPECT(tm) imaging system is capable of imaging large number of single photon emitting radioisotopes that are readily available, such as 1-125 (30 keV), TI-201 (75 keV), 1-123 (159 keV), ln-111 (171, 250 keV) and 1-131 (364 keV). The capability to image 1-125 is of particular noteworthy as 1-125 is commonly used in ex vivo molecular biology studies to label nucleic acids, antibodies, and ligands in addition to various Pharmaceuticals. New Pharmaceuticals can also be iodinated relatively easily. With X-SPECT(tm), these studies can now be performed non-invasively in vivo. In addition, the X-SPECT(tm) imaging system can perform dual isotope imaging simultaneously, such that one may look at drug delivery and efficacy simultaneously using two different tracers. The use of pinhole collimator allows the spatial resolution for SPECT imaging less than 1 mm. The x-ray CT system achieves high resolution better than 100 m. There is no similar instrument at the Ohio State University or other research centers in the State of Ohio. The instrument will be housed in a radioisotope certified laboratory animal facility in Wiseman Hall under the supervision of a research nuclear medicine technologist, who will work closely with the internal advisory committee. The principal investigator and the research nuclear medicine technologist have received training in the use of the A-SPECT(tm) imaging system (microSPECT component of the X-SPECT1 imaging system). Users will be trained by the principal investigator, the research nuclear medicine technologist, and laboratory animal veterinarian. The software will operate in a Window environment on a networked computer that will allow the investigators to access the data from distant sites. An hourly fee will provide funds for the annual service contract. The X-SPECT(tm) system will be integrated as a component of an Imaging Core Facility (shared resource). Thus, space and utilities for the instrument plus the salary and benefits for the research nuclear medicine technologist will be provided by the Ohio State University Comprehensive Cancer Center.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Biomedical Research Support Shared Instrumentation Grants (S10)
Project #
1S10RR019252-01A2
Application #
7334967
Study Section
Special Emphasis Panel (ZRG1-SBIB-R (30))
Project Start
2006-03-01
Project End
2007-02-28
Budget Start
2006-03-01
Budget End
2007-02-28
Support Year
1
Fiscal Year
2006
Total Cost
$216,938
Indirect Cost
Name
Ohio State University
Department
Physiology
Type
Schools of Medicine
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210